Therefore, it is possible to speculate on a downmodulation of Meg3 by the expressed KSHV miRNAs as an early event in the viral cycle followed by an upmodulation of Meg3 as a response of the host cell to the already triggered tumor growth. The gene discussed is MEG3; the disease is neoplasm.